- Home
- HEPA vs BACK Comparison
HEPA vs BACK Comparison
Compare HEPA & BACK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HEPA
- BACK
- Stock Information
- Founded
- HEPA 2013
- BACK 2000
- Country
- HEPA United States
- BACK United States
- Employees
- HEPA N/A
- BACK N/A
- Industry
- HEPA Biotechnology: Pharmaceutical Preparations
- BACK Medical Specialities
- Sector
- HEPA Health Care
- BACK Health Care
- Exchange
- HEPA Nasdaq
- BACK Nasdaq
- Market Cap
- HEPA 1.7M
- BACK 1.6M
- IPO Year
- HEPA N/A
- BACK 2019
- Fundamental
- Price
- HEPA $0.17
- BACK $0.66
- Analyst Decision
- HEPA
- BACK
- Analyst Count
- HEPA 0
- BACK 0
- Target Price
- HEPA N/A
- BACK N/A
- AVG Volume (30 Days)
- HEPA 31.4M
- BACK 4.2M
- Earning Date
- HEPA 04-15-2025
- BACK 04-15-2025
- Dividend Yield
- HEPA N/A
- BACK N/A
- EPS Growth
- HEPA N/A
- BACK N/A
- EPS
- HEPA N/A
- BACK N/A
- Revenue
- HEPA N/A
- BACK $72,050.00
- Revenue This Year
- HEPA N/A
- BACK N/A
- Revenue Next Year
- HEPA N/A
- BACK N/A
- P/E Ratio
- HEPA N/A
- BACK N/A
- Revenue Growth
- HEPA N/A
- BACK N/A
- 52 Week Low
- HEPA $0.12
- BACK $0.47
- 52 Week High
- HEPA $3.33
- BACK $7.75
- Technical
- Relative Strength Index (RSI)
- HEPA 36.41
- BACK 42.28
- Support Level
- HEPA $0.17
- BACK $0.50
- Resistance Level
- HEPA $0.19
- BACK $0.76
- Average True Range (ATR)
- HEPA 0.02
- BACK 0.11
- MACD
- HEPA 0.01
- BACK 0.02
- Stochastic Oscillator
- HEPA 28.55
- BACK 43.33
About HEPA Hepion Pharmaceuticals Inc.
Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan-cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease.
About BACK IMAC Holdings Inc.
IMAC Holdings Inc is a provider and manager of value-based, conservative medical care combining life science advancements with traditional medical care for movement-restricting diseases and conditions in IMAC Regeneration Centers and BackSpace clinics. Its Innovative Medical Advancements and Care (IMAC) Regeneration Centers combine medical and physical procedures to improve patient experiences and outcomes and reduce healthcare costs as compared to other available treatment options.